1.
Castillo JJ, Gustine JN, Meid K, Dubeau TE, Xu L, Yang G, Hunter ZR, Advani R, Palomba L, Treon SP. Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia. Haematologica [Internet]. 2018Sep.30 [cited 2026Nov.16];103(10):e466-e468. Available from: https://haematologica.org/article/view/8640